Literature DB >> 2479242

Sonographically guided paracentesis for palliation of symptomatic malignant ascites.

G J Ross1, H B Kessler, M R Clair, R A Gatenby, W H Hartz, L V Ross.   

Abstract

The technique, results, and complications of 109 consecutive sonographically guided therapeutic paracenteses performed on 43 patients with malignant ascites are summarized. A 5.5-French Sacks One-Step Catheter was used in all cases but five in which tissue resistance prohibited passage of the catheter through the abdominal wall. The procedure was performed on an inpatient basis 70 times and in an outpatient setting 39 times. Colonic, ovarian, and breast carcinomas accounted for over 50% of the tumors resulting in malignant fluid collections. Three complications (hypotension, 2.6%) were directly related to the procedure; two of them were fatal (1.6%). The amount of ascitic fluid drained within the first 24 hr averaged 3.5 l at rates of 100-150 ml/sec. Ninety-five procedures (87%, in 39 patients) resulted in improvement of symptoms after drainage as manifested by decreased pain from abdominal distention, alleviation of nausea, improved appetite, or decreased dyspnea. The duration of symptomatic relief ranged from 4 days to 45 days (mean, 10.4 days). Sonographically guided paracentesis is an effective procedure that can be performed for short-term relief of symptoms caused by malignant ascites.

Entities:  

Mesh:

Year:  1989        PMID: 2479242     DOI: 10.2214/ajr.153.6.1309

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  Efficacy and safety of reinfusion of concentrated ascitic fluid for malignant ascites: a concept-proof study.

Authors:  Rumi Hanada; Naosuke Yokomichi; Chihiro Kato; Kazumi Miki; Sachiko Oyama; Tatsuya Morita; Ryoko Kawahara
Journal:  Support Care Cancer       Date:  2017-11-22       Impact factor: 3.603

2.  A survey of treatment approaches of malignant ascites in Germany and Austria.

Authors:  C F Jehn; S Küpferling; G Oskay-Özcelik; D Lüftner
Journal:  Support Care Cancer       Date:  2014-12-21       Impact factor: 3.603

3.  Pocket ultrasound device as a complement to physical examination for ascites evaluation and guided paracentesis.

Authors:  Daniel Keil-Ríos; Hiram Terrazas-Solís; Alejandro González-Garay; Juan Francisco Sánchez-Ávila; Ignacio García-Juárez
Journal:  Intern Emerg Med       Date:  2016-02-19       Impact factor: 3.397

4.  Percutaneous management of malignant fluid collections.

Authors:  Leann S Stokes
Journal:  Semin Intervent Radiol       Date:  2007-12       Impact factor: 1.513

5.  Recommendations on the Use of Ultrasound Guidance for Adult Abdominal Paracentesis: A Position Statement of the Society of Hospital Medicine.

Authors:  Joel Cho; Trevor P Jensen; Kreegan Reierson; Benji K Mathews; Anjali Bhagra; Ricardo Franco-Sadud; Loretta Grikis; Michael Mader; Ria Dancel; Brian P Lucas; Nilam J Soni
Journal:  J Hosp Med       Date:  2019-01-02       Impact factor: 2.960

6.  [Methods of symptom control in malignant ascites].

Authors:  Astrid Bodisch; Christian Muschitz; Meinolf Karthaus
Journal:  Wien Med Wochenschr       Date:  2008

Review 7.  Drainage of malignant ascites: patient selection and perspectives.

Authors:  Maciej Stukan
Journal:  Cancer Manag Res       Date:  2017-04-12       Impact factor: 3.989

8.  Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis.

Authors:  Bruce Crawford; Elizabeth Piault; Walter Gotlieb; Florence Joulain
Journal:  Patient Relat Outcome Meas       Date:  2012-06-21

9.  Management of drainage for malignant ascites in gynaecological cancer.

Authors:  Chumnan Kietpeerakool; Siwanon Rattanakanokchai; Nampet Jampathong; Jatupol Srisomboon; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2019-12-11

10.  Mechanical Modulation of Ovarian Cancer Tumor Nodules Under Flow.

Authors:  Christina Conrad; Kaitlin Moore; William Polacheck; Imran Rizvi; Giuliano Scarcelli
Journal:  IEEE Trans Biomed Eng       Date:  2021-12-23       Impact factor: 4.538

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.